Revolution Medicines: Insider Ownership Update
Ticker: RVMD · Form: 4 · Filed: Apr 17, 2026 · CIK: 0001628171
| Field | Detail |
|---|---|
| Company | Revolution Medicines, Inc. (RVMD) |
| Form Type | 4 |
| Filed Date | Apr 17, 2026 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: insider-filing, form-4
TL;DR
Mark Goldsmith updated his Revolution Medicines holdings on 4/15/26. Check the filing for details.
AI Summary
On April 17, 2026, Mark A. Goldsmith filed a Form 4 with the SEC, reporting changes in beneficial ownership of securities for Revolution Medicines, Inc. The filing details transactions that occurred on April 15, 2026. The company is involved in Biological Products.
Why It Matters
Form 4 filings indicate changes in stock ownership by company insiders, which can signal their confidence in the company's future prospects.
Risk Assessment
Risk Level: low — This is a routine Form 4 filing reporting changes in beneficial ownership, not a material event like an acquisition or earnings miss.
Key Players & Entities
- Mark A. Goldsmith (person) — Reporting Person
- Revolution Medicines, Inc. (company) — Issuer
- 0001628171 (company) — Issuer CIK
- 0001246842 (person) — Reporting Person CIK
- 2026-04-17 (date) — Filing Date
- 2026-04-15 (date) — Period of Report
FAQ
Who is the reporting person in this filing?
The reporting person is Mark A. Goldsmith.
What company is this Form 4 filing related to?
This filing is related to Revolution Medicines, Inc.
What is the filing date of this document?
The filing date is April 17, 2026.
What period does this filing cover?
The period of report is April 15, 2026.
What is the CIK for Revolution Medicines, Inc.?
The CIK for Revolution Medicines, Inc. is 0001628171.
Filing Details
This Statement of Changes in Beneficial Ownership (Form 4) was filed with the SEC on April 17, 2026 by Mark A. Goldsmith regarding Revolution Medicines, Inc. (RVMD). Form 4 filings disclose purchases, sales, or other changes in ownership by company insiders such as officers, directors, and major shareholders.